Thomas F. Doyle is VP Strategic Initiatives at VIROPHARMA INC (VPHM). They have made 4 open-market trades across 1 company since 2006, most recently 2014-01-24.
CIK 0001187172
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2009, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VPHM | 48,878 | — |
Shares reported on the most recent Form 4, priced at the 2014-01-28 close. 1 holding could not be priced and is excluded from the total.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.